Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1WAL0921----1件: 222 💬
2Wangbi granules----1件: 46 💬
3Wangbi granules simulant----1件: 46 💬
4Warfarin1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬15件: 6, 8, 13, 19, 46, 48, 49, 66, 85, 86, 88, 91, 96, 97, 222 💬
5Warfarin 10 mg1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬2件: 96, 97 💬
6Warfarin Potassium2件: Potassium,
Warfarin		4件: Warfarin sodium ,
Warfarin potassium ,
Potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 88 💬
7Warfarin Sodium1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬3件: 48, 49, 222 💬
8Warfarin Sodium Tablets1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 46 💬
9Warfarin+ Vitamin K1件: Warfarin3件: Warfarin sodium ,
Warfarin potassium ,
Warfarin 💬 		2件: NQO1,
VKORC1 💬 		5件: Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 46 💬
10Warm compress prior to injection of glatiramer acetate2件: Acetate,
Glatiramer		1件: Glatiramer acetate 💬 20件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagocytosis, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
11Water1件: Water1件: Water 💬 --36件: 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
12Water exercises1件: Water1件: Water 💬 --1件: 46 💬
13WATER FOR INJECTION1件: Water1件: Water 💬 --1件: 35 💬
14Water for injections1件: Water1件: Water 💬 --1件: 299 💬
15WATER FOR INJECTIONS, EP1件: Water1件: Water 💬 --1件: 299 💬
16Water immersion1件: Water1件: Water 💬 --1件: 97 💬
17Water-soluble Ubiquinol2件: Ubiquinol,
Water		1件: Water 💬 --1件: 57 💬
18WAY-130799----1件: 13 💬
19WAY-177005----1件: 46 💬
20WD-1603----1件: 6 💬
21WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
22WD-1603 Carbidopa-Levodopa Extended-Release Tablets2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
23WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: Levodopa ,
Carbidopa 💬 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6 💬
24Weancare-domus----1件: 6 💬
25Wearable brain-computer interface devices----1件: 6 💬
26WelChol----1件: 79 💬
27Wellbutrin (bupropion)1件: Bupropion3件: Bupropion hydrochloride ,
Bupropion ,
Bupropion hydrobromide 💬 		2件: SLC6A2,
SLC6A3 💬 		8件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 96 💬
28WFI----1件: 96 💬
29Whale blubber oil----1件: 46 💬
30Wharton Jelly Mesenchymal stem cells----1件: 97 💬
31Wharton's jelly derived mesenchymal stem cell----1件: 90 💬
32WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS----1件: 36 💬
33WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS----1件: 2 💬
34Wheat1件: Wheat1件: Wheat 💬 --5件: 6, 53, 97, 98, 266 💬
35Wheat bran2件: Wheat,
Wheat bran		1件: Wheat 💬 --1件: 6 💬
36Wheat/milk free diet (W/MFD) group1件: Wheat1件: Wheat 💬 --1件: 53 💬
37Whey1件: Whey---4件: 6, 46, 96, 97 💬
38Whey protein1件: Whey---2件: 6, 96 💬
39Whey Protein Milk-Derived Exosomes1件: Whey---1件: 97 💬
40Whey Protein Supplement1件: Whey---1件: 6 💬
41Whey Protein&Prebiotic Supplement1件: Whey---1件: 46 💬
42White chocolate (0% cocoa)1件: Cocoa---1件: 6 💬
43Whole Blood1件: Whole Blood1件: Blood, whole 💬 --9件: 44, 45, 50, 65, 86, 177, 226, 283, 299 💬
44Whole blood sample1件: Whole Blood1件: Blood, whole 💬 --1件: 177 💬
45Whole body planar SPECT imaging (15 Minutes post-injection)----1件: 46 💬
46Whole body planar SPECT imaging (18-20 Hours post-injection)----1件: 46 💬
47Whole body planar SPECT imaging (180 Minutes post-injection)----1件: 46 💬
48Whole body planar SPECT imaging (60 Minutes post-injection)----1件: 46 💬
49Whole body Protein turnover----4件: 19, 46, 96, 299 💬
50Whole body Protein Turnover Study----1件: 299 💬
51Whole Lung Lavage(WLL)----1件: 229 💬
52WHOLE WHEAT MUFFIN1件: Wheat1件: Wheat 💬 --1件: 97 💬
53Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed1件: Tomato---1件: 298 💬
54Will take vitamin E 800mg/day1件: Vitamin E1件: Vitamin E 💬 --1件: 46 💬
55Willfact----1件: 288 💬
56Wilzin----1件: 171 💬
57WIN-1001X----1件: 6 💬
58With U-VANCO (vancomycin hydrochloride)1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 70 💬
59Withania somnifera----1件: 2 💬
60Withdrawal----1件: 57 💬
61Withhold IS (B cell depletion therapy)----7件: 13, 35, 46, 49, 50, 51, 107 💬
62Withhold IS (MMF or MPA)----7件: 13, 35, 46, 49, 50, 51, 107 💬
63Withhold IS (MTX)----7件: 13, 35, 46, 49, 50, 51, 107 💬
64Withholding Levodopa1件: Levodopa1件: Levodopa 💬 5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
65Without Anticoagulation----1件: 49 💬
66Without U-VANCO (vancomycin hydrochloride)1件: Vancomycin2件: Vancomycin ,
Vancomycin hydrochloride 💬 		--1件: 70 💬
67WM (Shentong Granules)----1件: 66 💬
68WMT----1件: 96 💬
69Wound topically irrigated with 500mg TXA----1件: 70 💬
70WRAIR-PAM-CF1----1件: 299 💬
71Wristband physical activity monitor----1件: 13 💬
72WTX101----1件: 171 💬
73Wuling Powder----1件: 6 💬
74WVE-0031件: WVE-003---1件: 8 💬
75WVE-004----2件: 2, 127 💬
76WVE-006----1件: 231 💬
77WVE-120101----1件: 8 💬
78WVE-120102----1件: 8 💬
79WVE-210201----1件: 113 💬
80WVE-210201 (suvodirsen)1件: Suvodirsen---1件: 113 💬
81WVE-N5311件: WVE-N531---1件: 113 💬